ketanserin has been researched along with Brain Neoplasms in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Felding, M | 1 |
Cold, GE | 1 |
Jacobsen, CJ | 1 |
Stjernholm, P | 1 |
Voss, K | 1 |
Elliott, JM | 1 |
Newberry, NR | 1 |
Cholewinski, AJ | 1 |
Bartrup, JT | 1 |
Briddon, SJ | 1 |
Carey, JE | 1 |
Flanigan, TP | 1 |
Newton, RA | 1 |
Phipps, SL | 1 |
Reavley, AC | 1 |
2 other studies available for ketanserin and Brain Neoplasms
Article | Year |
---|---|
The effect of ketanserin upon postoperative blood pressure, cerebral blood flow and oxygen metabolism in patients subjected to craniotomy for cerebral tumours.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Temperature; Brain; Brain Neoplasms; Cere | 1995 |
Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat C6 glioma cells.
Topics: Animals; Brain Neoplasms; Calcium; Cell Line; Dose-Response Relationship, Drug; Glioma; Ketanserin; | 1995 |